Clinical Trials Logo

Clinical Trial Summary

Evaluate quality of life after gynaecological malignancies diagnosis and treatment


Clinical Trial Description

gynecological cancers represent 10% of new cancer cases among women The main types are cervical, endometrial, ovarian and breast cancers. Each of these is unique in terms of prognosis, treatment, and age at onset. Early detection and improvement in treatment of these cancers has led to improvements in survival and, consequently, an increase in the number of survivors However, survival is accompanied by several negative aspects, such as fatigue, physical changes, sexual dysfunction, anxiety, and/or depression In addition to the physical and psychological disorders, survivors of gynecological cancer can experience economic problems related to work, or access to loans and insurance Although cancer occurs mainly in older adults, some people, particularly survivors of cervical and ovarian cancer, may experience cancer at an age where work is still of major importance For these women, a return to work represents a return to a normal social life and helps them to regain their self-esteem. Furthermore, work is a source of emotional and financial support and has been shown to enhance health-related quality of life by its positive effect on self-esteem Therefore, special attention must be paid to the well-being of survivors of gynecological cancer, as well as to their social and professional reintegratio is a multidimensional concept which encom passes physical and mental health as well as social well being. Although in recent decades, several studies have focused on and its determinants in survivors of gynecological cancer, has mainly been studied as it pertains to clinical data or with short follow-up durations. Our previous studies in long-term survivors of breast cancer have shown that the likelihood that will depend on other factors increases in line with the length of follow-up since diagnosis. Due to the improvement in medical science and continuing advancement in early detection and treatment, the expected survival time of cancer patients has become longer. This has resulted in an increased interest in exploring the health-related quality of life of cancer survivors. So, there is a consequent need to satisfy cancer patients' requirements which would enable them to live a healthy life In many cases, cancer patients experience sleep disturbance, depression and poor quality of life after being diagnosed and treated for cancer. So, the assessment of QoL among cancer patients is essential in order to design interventions for improving patients' outcomes Likewise, QoL assessment assists people realize how treatment, disease, and health impact quality of life. Furthermore, it helps to understand potential beneficial and risky aspects of a treatment thus help in weighing the impact of a decision ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05692102
Study type Observational
Source Assiut University
Contact
Status Not yet recruiting
Phase
Start date June 2023
Completion date June 2025

See also
  Status Clinical Trial Phase
Completed NCT04890327 - Web-based Family History Tool N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT05478876 - Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract N/A
Active, not recruiting NCT04899492 - Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery N/A
Terminated NCT03658109 - Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone Early Phase 1
Recruiting NCT05296512 - Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer Phase 2
Not yet recruiting NCT06398314 - Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors N/A
Completed NCT01679483 - Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer N/A
Completed NCT01444924 - Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery Phase 2
Recruiting NCT05053230 - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer N/A
Recruiting NCT04534075 - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial Phase 3
Active, not recruiting NCT04584957 - Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.) N/A
Completed NCT03292328 - Yoga for Symptoms of Nerve Damage Caused by Chemotherapy N/A
Completed NCT02459301 - A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies Phase 1
Completed NCT05131490 - Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients N/A
Active, not recruiting NCT03899376 - A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT N/A
Not yet recruiting NCT05407987 - Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) Phase 3
Recruiting NCT05891470 - To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT N/A
Not yet recruiting NCT05974995 - Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer N/A
Withdrawn NCT04368130 - SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care N/A